Transvenous Lead Extraction Outcomes in Hemodialysis Patients: Markers for Increased Mortality
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.70113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Aritra Paul und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrophysiology and Pacing, Cleveland Clinic Foundation-Main Campus, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Renal Dialysis, Device Removal, Prosthesis-Related Infections, Defibrillators, Implantable. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
The increasing use of cardiac implantable electronic devices (CIEDs) has led to a progressive increase in transvenous lead extraction (TLE) procedures. Due to immune compromise and systemic dysfunction, hemodialysis (HD) patients face higher risks of device‐related infection and need for TLE.
Objectives
This study evaluates TLE outcomes in dialysis patients and identifies predictors of 30‐day all‐cause mortality (ACM). Subgroup analysis focuses on dialysis patients undergoing TLE for infectious indications to determine predictors of adverse outcomes.
Methods
A retrospective review of TLE procedures performed from 2013 to 2022 ( n = 1614) identified 53 patients (3.3%) on HD. Procedural outcomes and 30‐day ACM were compared between HD and non‐HD cohorts using chi‐square tests. Predictors of 30‐day ACM were assessed with Cox regression. For HD patients with infectious indications ( n = 48), preprocedural findings, including pocket infection, positive blood cultures, and intracardiac mass, were evaluated for their impact on outcomes.
Results
Procedural success and complication rates were similar between HD and non‐HD groups, but 30‐day ACM was significantly higher in HD patients (13.2% vs. 2%; p < 0.001). Independent predictors of 30‐day ACM included HD, infectious indication for TLE, and NYHA Class 3/4 symptoms. Among HD patients with infectious indications, visualization of intracardiac mass on echocardiography predicted higher 30‐day ACM (33.3% vs. 6.1%; p = 0.01) and was confirmed as an independent predictor (OR 24.88; 95% CI 1.7–374.3; p = 0.02).
Conclusion
Dialysis is an independent predictor of 30‐day ACM after TLE. In dialysis patients with infectious indications, intracardiac mass is a prognostic factor for adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Electrophysiology and Pacing, Cleveland Clinic Foundation-Main Campus, Cleveland, Ohio, USA.
ORCID-Profile: Aritra Paul, Katsuhide Hayashi
Zitieren
APA
Paul, A., Hayashi, K., Bodi, K., Baranowski, B., Kochar, A., Martin, D., Taigen, T., Rickard, J., Hussein, A., Wazni, O., & Callahan, T. (2025). Transvenous Lead Extraction Outcomes in Hemodialysis Patients: Markers for Increased Mortality. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70113
Vancouver
Paul A, Hayashi K, Bodi K, Baranowski B, Kochar A, Martin D, et al. Transvenous Lead Extraction Outcomes in Hemodialysis Patients: Markers for Increased Mortality. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.70113
BibTeX
@article{Paul2025,
author = {Paul, Aritra and Hayashi, Katsuhide and Bodi, Kashyap and Baranowski, Bryan and Kochar, Arshneel and Martin, David and Taigen, Tyler and Rickard, John and Hussein, Ayman and Wazni, Oussama and Callahan, Thomas},
title = {Transvenous Lead Extraction Outcomes in Hemodialysis Patients: Markers for Increased Mortality},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.70113}
}
EUVIMED